Biomiicron

Chennai, India Founded: 1998 • Age: 28 yrs
Develops and produces pharmaceutical drugs for various medical categories including antiviral and pediatric care.
Annual revenue $1.2M Latest available
Total funding - Funding intelligence
Employees 108 Tracked headcount
Investors - Known backers
Products 10 Services tracked
Competitors 7 Brand Intelligence

About Biomiicron

Biomiicron is a company based in Chennai (India) founded in 1998. It operates as a B2B. The company has 108 employees as of March 31, 2024. Biomiicron offers products and services including Windose Tablet, Windose Syrup, Char-Sim, Orovit Active, and Hi-Q. Biomiicron operates in a competitive market with competitors including AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.

  • Headquarter Chennai, India
  • Employees 108 as on 31 Mar, 2024
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Biomiicron Pharma India Private Limited
  • Date of Incorporation 28 Jun, 2012
  • Jurisdiction Chennai, Tamil Nadu, India
Operational Areas
Healthcare → Nutrition, Wellness & Lifestyle Health Unlock Sub-Sector Unlock Segment
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $1.23 M (USD)
    -0.67
    as on Mar 31, 2024
  • Net Profit
    -$849.18 (USD)
    -126.08
    as on Mar 31, 2024
  • EBITDA
    $31.8 K (USD)
    92.52
    as on Mar 31, 2024
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    108

    as on Mar 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Biomiicron

Biomiicron offers a comprehensive portfolio of products and services, including Windose Tablet, Windose Syrup, Char-Sim, Orovit Active, and Hi-Q.

Product name locked
Category locked
Primary

Tablet for treating viral infections and supporting immune health.

Product name locked
Category locked
Locked

Syrup formulation for antiviral care in patients.

Product name locked
Category locked
Locked

Product for gastrointestinal relief and digestive support.

Product name locked
Category locked
Locked

Supplement for gynecological health and wellness needs.

Product name locked
Category locked
Locked

Treatment aid for infertility issues and reproductive care.

Product name locked
Category locked
Locked

Medication for intensive care and toxin management.

Product name locked
Category locked
Locked

Nutritional tablet for general health enhancement.

Product name locked
Category locked
Locked

Topical gel for pain relief and inflammation control.

Product name locked
Category locked
Locked

Preparation for pediatric health and child treatment.

Product name locked
Category locked
Locked

Product for respiratory relief and symptom management.

Funding Insights of Biomiicron

Premium access

Detailed funding history for Biomiicron

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Biomiicron

Investments
Premium access

Investment portfolio details for Biomiicron

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Biomiicron

Premium access

Detailed financials for Biomiicron

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Biomiicron Comparisons

Biomiicron Primary company
Description
Develops and produces pharmaceutical drugs for various medic...
Location
Chennai, India
Founded Year
1998
Annual Revenue
$1.23 M (USD)
Net Profit
-$849.18 (USD)
EBITDA
$31.8 K (USD)
Employees
108
As of 2024
Premium access

Peer comparison for Biomiicron

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Biomiicron

Biomiicron operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Pharmaceutical distribution and supply chain services are provided globally.
Locked Locked Locked
India's leading healthcare products distribution platform
Locked Locked Locked
Temperature-sensitive medicines are distributed via cold chain logistics by Keimed.
Locked Locked Locked
Provider of medical equipment, devices, and drugs distribution services
Locked Locked Locked
Serves as a distributor of a wide range of pharmaceutical drugs.
Locked Locked Locked
Distributor of pharmaceutical raw materials
Premium access

Detailed competitors of Biomiicron

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Biomiicron

Premium access

Complete news archive for Biomiicron

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Biomiicron

Biomiicron was founded in 1998.

Biomiicron is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.

As of Mar 31, 2024, the latest employee count at Biomiicron is 108.

Annual revenue of Biomiicron is $1.23M as on Mar 31, 2024.

Biomiicron Pharma is a pharmaceutical company based in Chennai, India, specializing in developing and manufacturing a wide range of health products. It offers items such as antiviral tablets, syrups for gastroenterology, gynecological treatments, and pediatric solutions through its manufacturing plants. The company emphasizes quality management and research to serve healthcare needs, focusing on categories like pain management and respiratory care.

Biomiicron's top competitors include Entero Healthcare, AmerisourceBergen and Keimed.

Biomiicron offers Windose Tablet, Windose Syrup, Char-Sim, Orovit Active, and 6 more products and services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available